Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Grants Priority Review for Genentech’s Actemra® sBLA for Giant Cell Arteritis, a Form of Vasculi

americanpharmaceuticalreviewJanuary 25, 2017

Tag: Genentech , autoimmune

PharmaSources Customer Service